Ramachandran C, Angelos K L, Walsh D A
J Biol Chem. 1983 Nov 10;258(21):13377-83.
32P-labeled perfused rat hearts were used to study the hormonal regulation of glycogen synthase. Following equilibration of perfused hearts with inorganic [32P]phosphate for 30 min, there was an incorporation of approximately 200 pmol of [32P]phosphate/unit of enzyme activity that arose from an exchange of [32P] phosphate with the endogenous [31P]phosphate. Maximum insulin-induced activation (10 milliunits/ml for 5 min), which promoted an I/D activity ratio change from 25% I to 40% I, was associated with a 22% decrease in phosphate content of the enzyme. With hearts from alloxan-induced diabetic animals, there was a 17% higher level of phosphate incorporation and a 4-fold decrease in % I glycogen synthase activity compared to normal animals, but with the diabetic tissue, insulin added to the perfusate had no effect on either the phosphate content or the activity ratio of the enzyme. In perfused hearts from normal animals, DL-isoproterenol and glucagon caused an increase in glycogen synthase phosphorylation of 85-100 pmol/unit of enzyme activity, while L-phenylephrine increased the phosphate content by only 20-35 pmol, but all three hormones caused the same degree of inactivation. The increase in cardiac glycogen synthase phosphorylation induced by DL-isoproterenol, glucagon, and L-phenylephrine was identical, with or without insulin pretreatment; this despite the fact that these three hormones promoted a 3- to 4-fold larger decrease in the enzyme activity ratio with the insulin-treated tissue. In perfused diabetic hearts, DL-isoproterenol, glucagon, and L-phenylephrine caused increased phosphorylation of glycogen synthase without affecting the albeit already low activity ratio of the enzyme. These results show that in the intact perfused heart the same degree of glycogen synthase inactivation can occur as a consequence of differing degrees of phosphorylation, presumably due to phosphorylation at different sites promoted by different second messengers. Conversely, the data indicate that the same extent of phosphorylation, as stimulated by the same second messenger, can inactivate glycogen synthase by different amounts depending upon the prior phosphorylation state of other sites in the protein.
用32P标记的灌注大鼠心脏来研究糖原合酶的激素调节。在用无机[32P]磷酸盐使灌注心脏平衡30分钟后,每单位酶活性大约有200皮摩尔的[32P]磷酸盐掺入,这是由于[32P]磷酸盐与内源性[31P]磷酸盐的交换所致。最大胰岛素诱导激活(10毫单位/毫升,持续5分钟)使I/D活性比值从25%的I型变为40%的I型,同时酶的磷酸盐含量降低了22%。与正常动物相比,用四氧嘧啶诱导的糖尿病动物心脏的磷酸盐掺入水平高17%,I型糖原合酶活性百分比降低4倍,但对于糖尿病组织,灌注液中添加胰岛素对酶的磷酸盐含量或活性比值均无影响。在正常动物的灌注心脏中,DL -异丙肾上腺素和胰高血糖素使糖原合酶磷酸化增加85 - 100皮摩尔/单位酶活性,而L -去氧肾上腺素仅使磷酸盐含量增加20 - 35皮摩尔,但这三种激素导致的失活程度相同。无论有无胰岛素预处理,DL -异丙肾上腺素、胰高血糖素和L -去氧肾上腺素诱导的心脏糖原合酶磷酸化增加是相同的;尽管这三种激素使胰岛素处理的组织中酶活性比值降低了3至4倍。在灌注的糖尿病心脏中,DL -异丙肾上腺素、胰高血糖素和L -去氧肾上腺素使糖原合酶磷酸化增加,而不影响该酶尽管已经很低的活性比值。这些结果表明,在完整的灌注心脏中,由于不同程度的磷酸化,可能是由于不同第二信使促进的不同位点的磷酸化,糖原合酶可发生相同程度的失活。相反,数据表明,由相同第二信使刺激的相同程度的磷酸化,根据蛋白质中其他位点的先前磷酸化状态,可使糖原合酶失活的程度不同。